Rainbow Biosciences is headquartered in the city of Houston, home of the largest medical complex in the world - the Texas Medical Center. In addition to some of the country's top research hospitals and facilities, Houston is home to more than 160 biotechnology companies and academic partnerships.
RBCC has begun to leverage these resources, delivering the newest and most sought-after biotech innovations to the scientific and medical communities.
RBCC is currently in talks with a promising company based in Houston, Texas, the home of the Texas Medical Center. The undisclosed company at current holds rights to eleven patents originally issued by NASA with a range of expertise from stem cell research to cancer and back to sickle cell anemia. Once the partnership is finalized, the two companies will work together to tap into the adult stem cell research industry – a market that is expected to reach a worth of $2.4 billion by 2015.
Rainbow Biosciences, LLC - a division of Rainbow Coral Corp. (RBCC) - is a new company focused on identifying, developing and marketing the next generation of bioscience solutions for the healthcare and scientific communities.
The company reached a major milestone recently in acquiring a new equity interest in emerging biotech game-changer Nano3D Biosciences (n3D). Nano3D's incredible new product, the Bio-Assembler, will soon allow researchers to dramatically shorten the development timeline for advanced new drugs and treatments while generating massive returns to investors.
In partnering with n3D, RBCC is poised for explosive growth in the biotech market, becoming a major new source of cutting-edge innovation.
The company is exploring several other opportunities within this sector, creating a rare opportunity for investors to become part of a multi-billion dollar industry just as it begins to take off.
In an exciting new development, RBCC has signed a Letter of Intent (LOI) with an emerging industry powerhouse, Amarantus Biosciences, Inc. This is a company that's focused on developing diagnostics and therapeutics to tackle Parkinson's and other neurologic, degenerative diseases. Over 6 million patients worldwide suffer from Parkinson's. With RBCC, the company hopes to make that number zero.
Rainbow Coral Corp. is a fully reporting SEC company, publicly traded on the OTC Market under the symbol, “RBCC”, and within the OTCQB market tier. As such, Business, Operational, and Financial information on Rainbow Coral Corp. is fully transparent and available to public view.
A/S: 250 Million O/S: 11.4 Million - as of 2/15/13
(Please note the share structure posted is what we have gathered but can change on a daily basis. Contact the Company or Transfer Agent to get the most current information.)
Disclaimer: The following Press Releases have not been investigated by Wall Street Surfers, therefore we have no idea if the content of this news is based on Fact or Fiction. Although the links for the following press releases may be from a familiar and reputable company , you should NOT assume that a press wire hosted by a website you are familiar with is accurate just because it is on their site. Wall Street Surfers will not be held responsible for any news release including and not limited to misleading or non-factual content, or the accuracy of the identity of the given source of the press release.
(these are only sources and not always up to date)
If you are new to trading penny stocks we strongly advise you to spend some time trading virtual money. They say that “You never really become a real trader until you wipeout your portfolio.” We say take that wipeout while not losing your real money.
Here are a few sites where you can easily set up a virtual account:
Market Data 
Markets 
AI
